Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Practical steps to enhance personal finance management skills, including tracking spending, setting goals, and using budgeting tools effectively.
23,748 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Both ServiceNow and Salesforce fell roughly 5% on the latest trading session as AI licensing concerns rattled investo...
A leading global shipping ETF is drawing attention for its current yield and rebound potential as sea lanes remain vo...
Roughly $14 billion in Bitcoin options are set to expire this week, complicating the market as Middle East tensions a...
AMD posted a blowout Q1 FY2026 with record revenue and booming data-center sales. The company guides stronger-than-ex...
Bitcoin surged beyond the $82,000 level this week, reviving bullish chatter while alerting analysts to rising risk as...
Investors are watching Cytek's 2026 earnings story unfold after Q1 results. This deep dive breaks down the key driver...
U.S. investors are watching three dividend aristocrats abroad as currency moves and energy swings threaten steady inc...
Ambiq Micro is navigating a crowded IoT market with its ultra-low power chips. This article breaks down what to expec...
Adobe stock faces a challenging year but shows signs of a turnaround as AI monetization accelerates and enterprise de...
Warren Buffett’s long run outperformed the market for 60 years, driven by durable moats and patient capital. Learn th...
Ready to invest $10,000 in energy? This guide argues for a top-tier, cash-flow-driven pick and shows you how to maxim...